SCHEDULE: Vanguard Discloses 6.87% Stake in Hinge Health

Sentiment:

Beneficial Ownership Report


The Vanguard Group reported a 6.87% beneficial ownership stake in Hinge Health Inc. common stock as of December 31, 2025.

Summary

  • The Vanguard Group holds beneficial ownership of 2,605,532 shares of Hinge Health Inc. Common Stock.
  • This represents 6.87% of the total class of securities.
  • The Vanguard Group has shared voting power over 121,736 shares and shared dispositive power over 2,605,532 shares.
  • An internal realignment at The Vanguard Group, effective January 12, 2026, means the entity no longer performs portfolio management or administers proxy voting.
  • Following the realignment, certain subsidiaries or business divisions of The Vanguard Group, Inc. are expected to report beneficial ownership separately.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a neutral to slightly positive signal, as a major institutional investor maintains a significant stake, indicating continued confidence in Hinge Health's long-term prospects, despite the filing being a routine ownership disclosure.

Positives

  • The disclosure of a significant 6.87% stake by a major institutional investor like The Vanguard Group can be viewed as a vote of confidence in Hinge Health Inc.

Negatives

  • The filing does not contain information that would be considered negative for Hinge Health Inc.

Future Outlook

The Vanguard Group anticipates that certain subsidiaries or business divisions will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. following an internal realignment effective January 12, 2026.

Management Comments

  • "To the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities."

Industry Context

StockSavvy.ai notes that routine Schedule 13G filings provide transparency into the passive ownership stakes held by large institutional investors. The continued presence of a major fund manager like Vanguard on a company's cap table often signals a baseline level of institutional confidence, aligning with broader trends of passive investment growth.

Stakeholder Impact

  • Shareholders gain transparency into the significant institutional ownership held by The Vanguard Group, which can influence market perception and liquidity.

Next Steps

  • The Vanguard Group's subsidiaries and/or business divisions are expected to report beneficial ownership separately in future filings.

Key Dates

DateDescription
12/31/2025Date of event which requires filing of this statement (beneficial ownership calculation date).
01/12/2026Effective date of The Vanguard Group, Inc.'s internal realignment, ceasing portfolio management and proxy voting services.
01/30/2026Date the Schedule 13G statement was signed and filed.

Recommendation

hold

The filing indicates a significant, passive institutional stake by The Vanguard Group, suggesting continued confidence from a major investor. However, it does not provide new operational or financial performance data to warrant a change from a 'hold' position based solely on this disclosure.

Keywords

Hinge Health, Vanguard Group, Schedule 13G, beneficial ownership, common stock, institutional investor, SEC filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.